Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-31Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 1997-03-17 / Int. J. Cancer 1997 Mar;70(6):706-15Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer
/in Hyperthermia, International Publications, Urothelial Carcinoma /von 1996-03-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Mar;34(4):887-93Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer
/in Hyperthermia, International Publications, Urothelial Carcinoma /von 1994-01-01 / Int J Hyperthermia 1994 Jan-Feb;10(1):31-40Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 1993-01-01 / Virchows Arch A Pathol Anat Histopathol 1993;422(5):351-5[Distribution of S-100 protein-positive dendritic cells in transitional cell carcinoma of human bladder and its relation to clinical prognosis]
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 1991-10-01 / Zhonghua Yi Xue Za Zhi 1991 Oct;71(10):579-80, 40
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de